The metabolic pathways regulated by FXR mainly include glucose, sterol metabolism, and lipid, and are believed to have the potential to improve conditions such as obesity, liver damage, and chronic inflammatory diseases (Xiang et al., 2021). The gene discussed is NR1H4; the disease is obesity disorder.